Recursion Pharmaceuticals Stock (RXRX)

Track Recursion Pharmaceuticals stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.

$3.15

▼ -1.22 (-27.79%) past year

Live · Updated May 28, 2:13 PM

Market Cap

$1.58B

P/E Ratio

—

1Y Return

-27.79%

EPS (TTM)

-$1.20

Read the latest TheStreet Pro articles mentioning Recursion Pharmaceuticals, including market roundups, portfolio updates, trade ideas, and investing analysis.

Articles

3 articles

trade-ideas Are We Moving on From the Nonsense?
Helene MeislerMay 15, 2024
RXRX EXPE OXY
market-commentary Times of Change
Helene MeislerJan 5, 2024
RXRX CLF IP
market-commentary Watch These Charts Closely as We Head Into Year-End and Early 2024
Helene MeislerDec 17, 2023
RXRX BABA GLD

Daily Diary Mentions

0 mentions

No diary mentions for RXRX yet.